Healthcare · NYSE/NASDAQ: CAH
CARDINAL HEALTH INC
Medical Distribution
Market Cap $53.02B
Verdict: Weak
Quality Scores
Multi-Bagger
25/100
Compounder Quality
42/100
Management Credibility
60/100
Governance
40/100
Cash Flow Quality
82/100
AI Summary
Cardinal Health operates as a critical pillar in the healthcare supply chain, yet its financial profile over the last decade reveals a business struggling with structural headwinds and massive legal liabilities. While revenue has ballooned from approximately $31B to over $220B, this top-line expansion has not translated into stable bottom-line growth, evidenced by erratic net income and technical insolvency. The company's balance sheet is currently impaired with negative stockholders' equity, primarily driven by multi-billion dollar opioid-related litigation settlements and asset write-downs.…
Top Opportunities
- Secular tailwinds in US healthcare spending
- Critical infrastructure role in drug distribution
- Significant revenue scale exceeding $200B
Top Risks
- Structural negative Stockholders Equity
- Extremely thin net margins (often <1%)
- Massive multi-billion opioid litigation settlements
Latest report: Read the annual report summary →
Unlock the full report
Full sections, financial charts, AI chat and PDF export are available with Premium.